USP9X expression is altered in a mouse model of PD [56], and a portion of USP9X localizes to Lewy Bodies in PD and DLBD, modulating the stability of α-synuclein via autophagy-mediated degradation [57]. Here, USP9X is linked to Parkinson disease.